Tricyclic antidepressant pharmacology and therapeutic drug interactions updated
By P. Gillman. British Journal of Pharmacology, 2007
645 citations recorded by the source corpus.
Subfields: Pharmacology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/ca2bb4484f66daaac81a00f3e72915a9797518d0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Psychiatry and Mental health
Citations in the corpus
- Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024, background): “…SNRIs can all inhibit the reuptake of 5-HT by SERTs, specially SSRIs have the selective inhibition on SERTs, which increase the concentration of 5-HT in the synaptic gap and play antidepressive roles by effecting on 5-HTRs in postsynaptic membrane, 343,344 which also activate the cAMP-PKA pathway.”
- SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation (2011, background): “However, the TCAs display activity across a variety of different receptors (Gillman, 2007), and new generations of monoamine transporter inhibitors with little or no affinity for other proteins have subsequently been developed.”
- A Social Media Study on the Effects of Psychiatric Medication Use (2019, background): “Antidepressant research has grown tremendously, ever since Imipramine, and other Tricyclic Antidepressants (TCAs) were discovered and found to be effective (Gillman 2007).”
- Exercise as a treatment for depression: A meta-analysis. (2016, background): “Combining different pharmacological drugs increase the risk of adverse effects or drug-drug interaction (Ferguson, 2001; Gillman, 2007), which necessitates further exploration of adjunction with nonpharmacological treatments.”
- Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants: 2016 Update (2017, background): “Tertiary and secondary amines along with their metabolites each have unique side effect profiles, as detailed in Supplemental Table S4.”
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders (2015, background): “, 2014); TCA (Anderson, 2000; Cohn et al., 1996; Danish University Antidepressant Group, 1986; Danish University Antidepressant Group, 1990; Danish University Antidepressant Group, 1993; Doogan and Langdon, 1994; Fabre et al., 1996; Feighner and Boyer, 1989; Furukawa et al., 2009; Gillman, 2007; Gua”
- Feather damaging behaviour in parrots: A review with consideration of comparative aspects (2009, background): “They also display a function in a1 receptor blockage and b receptor downregulation and postsynaptic antagonism of histamine H1-receptor and dopamine receptors (Gillman, 2007).”